You are on page 1of 41

THE LIVER AND ITS

DISORDERS

DR. APPIAH
Outline
• Introduction

• Functions of the liver

• Bilirubin metabolism

• Jaundice

• Inherited hyperbilirubinaemia

• Neonatal jaundice

• Laboratory diagnosis

DR. APPIAH'S LECTURE SERIES 2


Objectives
• Appreciate the tests that are used to assess the liver function.

• Explain the biochemical basis of the above liver function tests.

• Explain the biochemical changes seen in main hepatobiliary diseases.

• Explain the significance of serum ALT and AST (markers of inflammation


of liver) & γ-GT (diagnosis of hepatobiliary dysfunction)

• Differentiate between the three types of jaundice using liver enzymes,


bilirubin & urobilinogen
DR. APPIAH'S LECTURE SERIES 3
Introduction
• The liver is the largest solid organ in the body.

• In adults, it weighs 1.0–1.5 kg and its size is


maintained in relatively constant proportion to
body weight.

• It is comprised of a large right lobe and a


smaller left lobe, and is located in the upper
right quadrant of the abdomen under the lower
edge of the diaphragm.

• It is the only organ that has the capability to


regenerate completely after it has been
damaged or following a partial hepatectomy.
DR. APPIAH'S LECTURE SERIES 4
Functions of the liver
❑It is the site for the following:

➢Metabolism of carbohydrates, lipids and proteins

➢Conversion of β-carotenes into vitamin A

➢Synthesis of plasma proteins except immunoglobulins and


complement

➢Synthesis of clotting factors such as fibrinogen and factors II,V,VII,


IX, XII & XIII
DR. APPIAH'S LECTURE SERIES 5
• Site for the synthesis of lipoproteins, VLDL and HDL

• Site for the synthesis of primary bile acids

• Site for the detoxification of drugs and toxic substances

• Site for the storage of glycogen,iron, fat-soluble vitamins and vitamin B12

• Metabolism of steroid hormones (25-hydroxylation of vitamin D)


polypeptide hormones, and bilirubin.

DR. APPIAH'S LECTURE SERIES 6


Bilirubin metabolism
• 80% of the daily output of bilirubin is derived from the breakdown of
erythrocytes

• The remaining 20% of the output is from red cell precursors and haem
proteins e.g myoglobin, cytochrome & peroxidase

• The breakdown commences with the removal of the iron moiety

DR. APPIAH'S LECTURE SERIES 7


• Haem oxygenase then converts the
porphyrin ring to biliverdin Ixα

• This is then converted to bilirubin


IXα by biliverdin reductase

• Bilirubin is then transported to the


liver for further metabolism by
binding to albumin.

• It is taken up by the liver by a


facilitated transport system

DR. APPIAH'S LECTURE SERIES 8


• Ligandin Y and Z are transport proteins which are associated with
intracellular binding and transport of bilirubin

• In the hepatocytes, about 85% of bilirubin is conjugated with two


molecules of glucuronic acid in the smooth endoplasmic reticulum

• Most of the rest of bilirubin is conjugated with one sugar molecule to


form monoglucuronate-bilirubin. The addition of the sugar group
increases the solubility of the molecule.

• The enzymes involved are UDP glucose dehydrogenase, UDP-


glucuronyl transferase I and II
DR. APPIAH'S LECTURE SERIES 9
• The activity of UDP-glucuronyl transferase may be induced by
phenobarbitone and inhibited by novobiocin.

• The liver is the main site of bilirubin conjugation but it may occur in
the kidney and intestinal mucosa

• Bilirubin diglucuronide is actively secreted into the bile

DR. APPIAH'S LECTURE SERIES 10


• When conjugated bilirubin gets
to the terminal ileum and the
large intestines, the intestinal
flora deconjugates the bilirubin

• Bilirubin is then converted to


urobilinogen, mesobilinogen and
stercobilinogen.

• Some of the pigments undergo


an enterohepatic circulation.

DR. APPIAH'S LECTURE SERIES 11


DR. APPIAH'S LECTURE SERIES 12
• Urobilinogen is thus a normal constituent of the urine

• The pigments stercobilin contribute to the colour of the stool

• Normal adults do not excrete bilirubin in the urine and stool

DR. APPIAH'S LECTURE SERIES 13


Jaundice in adults
• The reference range of bilirubin in adults is up to 17.1 µmol/l

• Jaundice is characterized by the yellowish colouration of the tissues


due to retention of pigments

• Experienced physicians discern when blood [bilirubin] is about 35


µmol/l

DR. APPIAH'S LECTURE SERIES 14


• It becomes overt when levels are about 55-70 µmol/l

• Jaundice is a symptom of an underlying disease

• It may be due to pre-hepatic, hepato-cellular and post-hepatic causes

DR. APPIAH'S LECTURE SERIES 15


Pre-hepatic jaundice

• It may be due to haemolytic or non-haemolytic causes

• Haemolytic jaundice may be due to acquired (malaria) or congenital(G6PD


deficiency) causes

• It may also be due to ineffective erythropoiesis (pernicious anaemia) or


right sided congestive cardiac failure

DR. APPIAH'S LECTURE SERIES 16


• Typical serum bilirubin pattern of prehepatic hyperbilirubinemia is
increased unconjugated bilirubin and normal conjugated bilirubin.

• Non haemolytic jaundice is usually of congenital origin e.g Criggler-


Najjar and Gilberts’syndrome

DR. APPIAH'S LECTURE SERIES 17


Hepatocellular jaundice
• This may be due to defects in conjugation of bilirubin or defects in its
hepatic uptake

• Defects in conjugation may result from diffuse hepatic injury which


may occur in the following:
✓Acute, subacute, chronic and fulminant hepatitis

✓Effects of drugs or toxins such as paracetamol, alcohol, CCl4 and


halothane

DR. APPIAH'S LECTURE SERIES 18


• Defects in uptake may result from the effects of flavispidic acid

• The typical serum bilirubin pattern of hepatic hyperbilirubinemia is


increased unconjugated and conjugated bilirubin.

• Serum enzymes that indicate hepatocellular inflammation and cellular


damage within the liver, including ALT and AST, are also often
elevated

DR. APPIAH'S LECTURE SERIES 19


Intra-hepatic cholestasis
• This may occur in subacute or chronic hepatitis

• It may also be due to the effects of drugs such as:

✓17 α-alkylated steroids e.g methyltestosterone or norethisterone

✓Phenothiazine e.g chlorpromazine

DR. APPIAH'S LECTURE SERIES 20


✓Antibiotics e.g oleandomycin and erythromycin

✓Penicillin sensitivity

• It may also occur in some forms of cirrhosis, especially primary biliary


cirrhosis

DR. APPIAH'S LECTURE SERIES 21


Post-hepatic jaundice
• This is usually due to mechanical obstruction of the biliary tree as a
result of:

✓Gallstones

✓Carcinoma of the head of the pancreas

✓Scarring from infection

DR. APPIAH'S LECTURE SERIES 22


• The typical serum bilirubin pattern of post hepatic hyperbilirubinemia
is increased conjugated bilirubin but normal unconjugated bilirubin.

• Serum enzymes that indicate biliary cell damage, including alkaline


phosphatase and GGT, are also often elevated.

DR. APPIAH'S LECTURE SERIES 23


Summary

DR. APPIAH'S LECTURE SERIES 24


An approach to jaundice

• Is it isolated elevation of serum bilirubin ?

• If so, is the ↑unconjugated or conjugated fraction?

• Is it accompanied by other liver test abnormalities ?

• Is the disorder hepatocellular or cholestatic?

• If cholestatic, is it intra- or extrahepatic?


DR. APPIAH'S LECTURE SERIES 25
• These can be answered with a thoughtful

✓History and physical examination

✓Interpretation of laboratory tests and

✓Radiological tests and procedures.

DR. APPIAH'S LECTURE SERIES 26


Inherited hyperbilirubinaemia
• This may be classified into unconjugated and conjugated types

• The congenital unconjugated hyperbilirubinaemias are Gilberts and


Criggler-Najjar Syndromes

• The congenital conjugated hyperbilirubinaemias are Dubin Johnson


and Rotor Syndromes

DR. APPIAH'S LECTURE SERIES 27


Gilbert’s syndrome
• This is a heterogenous condition and has an estimated prevalence of 3–8%
in the general population.

• The defect is a TA insertion in the TATA repeat box of the gene promoter
region. Homozygosity reduces the capacity for gene expression

• It is characterized by the defective uptake of bilirubin by the hepatocytes

• There may be an associated reduction in the life span of the erythrocytes

DR. APPIAH'S LECTURE SERIES 28


• Their serum [bilirubin] is usually between 20-40 µmol/l and rarely
exceeds 80 µmol/l

• Their serum bilirubin levels may rise during intercurrent illness or


during fasting

• It may present at any age but it commonly presents in the second


decade of life.

DR. APPIAH'S LECTURE SERIES 29


Crigler-Najjar Syndrome
• This is characterized by the deficiency of hepatic glucuronyl
transferase

• Two types of the condition have been described;

✓Type I is characterized by a marked deficiency of the enzyme which


may lead to death from kernicterus at infancy

DR. APPIAH'S LECTURE SERIES 30


• Type II is characterized by a partial deficiency of the defective enzyme

• The serum [bilirubin] may be reduced by drugs which induce hepatic


enzyme synthesis e.g phenobarbitone

• Crigler-najjar Syndrome usually presents at birth

DR. APPIAH'S LECTURE SERIES 31


Dubin- Johnson Syndrome
• This is a rare and benign condition which is characterized by defective
excretion of bilirubin but not bile salts

• It is associated with a slightly raised serum conjugated bilirubin

• Affected subjects present with bilirubinuria but the Alkaline


Phosphatase is normal

DR. APPIAH'S LECTURE SERIES 32


• There may be hepatomegaly

• The liver of affected persons has orange-yellow granules

• The liver of subjects is usually dark brown

DR. APPIAH'S LECTURE SERIES 33


Rotor Syndrome
• This is also characterized by defective excretion of conjugated
bilirubin into the biliary tree.

• The liver of affected subjects does not have orange-yellow granules

DR. APPIAH'S LECTURE SERIES 34


Neonatal jaundice
• The reference range of bilirubin in neonates is 8-67 µmol/l

• In the first week of a neonates life, there may be a physiological


hyperbilirubinaemia

• The serum [bilirubin] may rise to as high as 200 µmol/l and is usually
prolonged in preterm neonates.

DR. APPIAH'S LECTURE SERIES 35


Causes of neonatal jaundice
• Haemolytic disease e.g blood group incompatibilty and G6PD
deficiency.

• Immaturity of the hepatic processes for uptake and excretion of


bilirubin.

• Interference with hepatic transport functions by drugs e.g progesterone


or steroids with progesterone-like activity

DR. APPIAH'S LECTURE SERIES 36


• Neonatal hyperbilirubinaemia may be aggravated by:

✓Acid-Base disturbances

✓Hypoxia

✓hypoglycaemia

DR. APPIAH'S LECTURE SERIES 37


• The course and severity of neonatal jaundice may be influenced by:

✓Drugs such as salicylates and sulphonamides which compete for binding to


albumin

✓Novobiocin which inhibits the glucuronyl transferase system

✓Drugs which cause haemolysis

▪ If the level of unconjugated bilirubin exceeds the plasma binding capacity it


will lead to kernicterus

DR. APPIAH'S LECTURE SERIES 38


• Biliary atresia may lead to cholestatic jaundice

• It’s a blockage in the tubes(ducts) that carry bile from liver to the
gallbladder.

• This congenital condition occurs when the bile ducts inside or outside
the liver do not develop normally

• Its not known why the biliary system fails to develop normally

DR. APPIAH'S LECTURE SERIES 39


Lab Diagnosis of Jaundice

Prehepatic Intrahepatic Posthepatic


Features
(Heamolytic) (Hepatocellular) (Obstructive)

Unconjugated ↑ Normal Normal

Conjugated Normal ↑ ↑

AST or ALT Normal AST↑ ↑↑ Normal

Alkaline phos.
and GGT
Normal Normal ↑↑
Urine bilirubin Absent Present Increased

Urobilinogen Increased Present Absent


DR. APPIAH'S40
LECTURE SERIES
Case study
❑14-year-old boy presented to his doctor complaining of abdominal pain, nausea,
and weakness. His previous medical history included recent travel to Africa to
visit relatives. On examination he was jaundiced, had a fever, and an enlarged
liver with tenderness. The results of his biochemical tests for the liver were as
follows (reference ranges are given in brackets):

• Total protein 71 g/L (60–80)


• Albumin 40 g/L (35–80)
• Bilirubin 233 lmol/L (0–20)
• Alkaline phosphatase 307 IU/L (30–130)
• Aspartate aminotransferase 1825 IU/L (5–50)
• Gamma-glutamyl transferase 282 IU/L (5–55)

➢What is the differential diagnosis?

DR. APPIAH'S LECTURE SERIES 41

You might also like